New Device Approved for Enlarged Prostate

MONDAY, Sept. 16 (HealthDay News) -- The UroLift system has been approved by the U.S. Food and Drug Administration to treat low or blocked urine flow in men aged 50 and older who have an enlarged prostate.

The prostate is a walnut-sized gland that's right below the bladder in males. When the gland becomes enlarged, as tends to happen in older men, it can restrict the flow of urine.

The new device, which helps prevent the prostate from pressing on the urethra, was evaluated in clinical studies involving 274 men between the ages of 49 and 86. Participants given the device reported fewer symptoms of enlarged prostate and a better quality of life, the FDA said.

The most common adverse reactions included pain or burning during urination, blood in the urine and incomplete emptying of the bladder.

The UroLift system is produced by NeoTract Inc., based in Pleasanton, Calif.

More information

To learn more about enlarged prostate, visit Medline Plus.

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.